期刊文献+

前列腺癌根治术后无瘤生存期的影响因素分析 被引量:3

Analysis of factors influencing the disease-free survival after radical prostatectomy for prostate adenocarcinoma
原文传递
导出
摘要 目的探讨前列腺癌根治术后无瘤生存期的影响因素及Bcl2、CerbB2、Ki67在前列腺癌中的表达及意义。方法回顾性分析51例前列腺癌患者根治术后无瘤生存期的影响因素,应用Cox比例风险模型进行多因素统计分析。对其中15例术前穿刺标本及手术切除标本行3种癌基因蛋白免疫组化检查,分析其表达与术后无瘤生存期的关系。结果Cox比例风险模型发现有意义的因素为年龄(P=0.011)、术前雄激素全阻断治疗(P=0.017)、阳性切缘(P=0.000)、切除标本Gleason评分(P=0.002)、术前或术后行睾丸切除(P=0.040)。前列腺癌穿刺标本、切除标本中Bcl2、CerbB2、Ki67蛋白表达与术后无瘤生存期存在相关性。结论标本阳性切缘是影响无瘤生存期的因素,前列腺癌根治术术前雄激素全阻断治疗可提高患者术后无瘤生存期,术中探查未发现肿大淋巴结时未行盆腔淋巴结清扫对术后无瘤生存时间无明显影响,术前或术后睾丸切除患者的无瘤生存期明显好于未行睾丸切除患者。Ki67、Bcl2与CerbB2可作为术前、术后预测前列腺癌患者根治术后无瘤生存期的指标。 Objective To analyze the factors that influence the disease-free survival time after radical prostatectomy for prostate adenocarcinoma and to study the expression and significance of Bcl-2,C-erbB-2,Ki-67 in prostate adenocarcinoma. Methods A total of 51 cases of prostate adenocarcinoma undergoing radical prostatectomy were reviewed.Cox proportional hazard model was used to investigate the impact and co-impacts of the factors,which included age, preoperative PSA level,Gleason scores of biopsies and operative specimens,EPE,MR,SVI,LN,PAT,PRT and having testes or not during follow-up.Immunohistochemical staining was used in biopsies and resected specimens to evaluate the positivity of Bcl-2,C-erbB-2,Ki-67 in 15 of the 51 cases. Results In stepwise Cox proportional hazards model, the prognostic factors for recurrence were age(P=0.011),maximal androgen blockade(P=0.017), positive margin of resection(P=0.000),postoperative Gleason score(P=0.002),having testes or not after operation(P=0.040).The expressions of 3 types of proteins showed negative correlation with the prognosis of prostate carcinoma. Conclusions Among clinicopathologic factors,positive resected margin is the most powerful prognostic factor.Patients will benefit from maximal androgen blockage before radical prostatectomy.Disease-free survival after radical prostatectomy is not influenced by not having pelvic lymphadenectomy after finding no enlarged lymph nodes intraoperatively.Not preserving testes after prostatectomy is a favorable factor.The prognosis of prostate carcinoma can be predicted with the expressions of Bcl-2,C-erbB-2 and Ki-67 in biopsies or resected specimens.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2005年第6期379-382,共4页 Chinese Journal of Urology
  • 相关文献

参考文献9

  • 1Borre M, Bentzen SM, Nerstrom B, et al. Tumor cell proliferation and survival in patients with prostate cancers followed expectantly. J Urol,1998,159:1609-1614.
  • 2Babaian RJ, Troncoso P, Bhadkamkar BA, et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy.Cancer,2001,91:1414-1422.
  • 3Koksal IT, Ozcan F, Kadioglu TC, et al. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol,2000,37:670-678.
  • 4Obek C, Lai S, Sadek S, et al. Age as a prognostic factor for disease recurrence after radical prostatectomy. Urology, 1999,54:533-541.
  • 5Pienta K,Demers R, Hoff M,et al. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit Tricounty Area,1973 to 1987. J Urol,1995,45:93-102.
  • 6Ohori M, Wheeler TM, Kattan MW, et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol,1995,154:1818-1824.
  • 7Tefilli MV, Gheiler EL, Tiguert R, et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol, 1998,160: 802 -810.
  • 8Wu TT,Chen JH,Lee YH. The role of bcl-2,p53 and Ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma. J Urol,2000,163:758-760.
  • 9姚宏,姚巍,徐燕杰,袁瑞香,王虹,平苏萍,赵玛丽,张庆升.原癌基因C-erb B-2蛋白产物在前列腺癌中的表达[J].中华泌尿外科杂志,1994,15(5):357-358. 被引量:2

二级参考文献1

  • 1徐燕杰,中华泌尿外科杂志,1993年,14卷,103页

共引文献1

同被引文献40

  • 1项永兵.利用数据库系统软件处理日期型数据的技巧[J].中国卫生统计,1996,13(1):47-47. 被引量:2
  • 2高江平,洪宝发.前列腺癌内分泌治疗的进展[J].中华外科杂志,2006,44(6):393-395. 被引量:7
  • 3Hao XP, Willis JE, Pretlow TG, et al. Loss of fragile histidine triad expression in coloreetal carcinomas and premalignant lesions. Cancer Res, 2000, 60: 18-21.
  • 4Yu R, Heaney A, Lu W, et al. Pituitary tumor transforming gene (PTTG) causes aneuploidy and p53-dependent and p53- independent apoptosis. J Biol Chem, 2000, 275: 36502- 36505.
  • 5Badalament RA, O' Toole RV, Young DC, et al. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Cancer, 1991, 67:3014-3023.
  • 6Gowardhan B, Douglas DA, Mathers ME, et al. Evaluation of the fibrohlast growth factor system as a potential target for therapy in human prostate cancer. Br J Cancer, 2005, 92: 320-327.
  • 7Kokontis J, Takakura K, Hay N, et al. Increased androgen receptor activity and altered e-myc expression in prostate cancer eells after long-term androgen deprivation. Cancer Res, 1994, 54: 1566-1573.
  • 8Janoff DM, Peterson C, Mongoue-Tchokote S, et al. Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer. BJU Int, 2005, 96: 503-507.
  • 9Gancarczyk K J, Wu H, McLeod DG, et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. Urology, 2003, 61: 589-595.
  • 10Freedland SJ, Aronson WJ, Terris MK, et al. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer, 2003, 98:2344- 2350.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部